No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Behcet Disease is a rare, chronic, systemic inflammatory disorder that affects the blood vessels throughout the body. It is classified as an autoimmune disorder, and is characterized by recurrent oral and genital ulcers, skin lesions, and inflammation of the eyes. Symptoms can vary from mild to severe, and can include joint pain, fatigue, and vision problems. Treatment typically involves a combination of medications, such as corticosteroids, immunosuppressants, and biologics.
The Behcet Disease market is a subset of the Allergy and Immunology market, and is composed of pharmaceutical companies, biotechnology companies, and medical device companies. These companies develop and manufacture products to diagnose, treat, and manage the symptoms of Behcet Disease.
Some companies in the Behcet Disease market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more
